Injection Behaviors and Use of Syringe Service Programs over Time among People Who Inject Drugs in Baltimore, Maryland

References

• Allen, S. P. J., Weir, B., Holtgrave, D., & Sherman, S. (2017, July 23–26). Effects of syringe distribution policy change at a syringe services program in Baltimore, MD: A forecast analysis [Paper presentation]. 9th IAS Conference on HIV Science (IAS 2017), Paris, France. Retrieved from https://www.natap.org/2017/IAS/IAS_100.htm
   Google Scholar
• Anderson, E. S., Russell, C., Basham, K., Montgomery, M., Lozier, H., Crocker, A., Zuluaga, M., & White, D. A. (2020). High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department. PLOS One, 15(6), e0233927. https://doi.org/10.1371/journal.pone.0233927
   PubMed Web of Science ®Google Scholar
• Andía, J. F., Deren, S., Robles, R. R., Kang, S. Y., & Colón, H. M. (2008). Peer norms and sharing of injection paraphernalia among Puerto Rican injection drug users in New York and Puerto Rico. AIDS Education and Prevention, 20(3), 249–257. https://doi.org/10.1521/aeap.2008.20.3.249
   PubMed Web of Science ®Google Scholar
• Artigiani, E. E., & Wish, E. D. (2014). Patterns and trends of drug abuse in the Baltimore/Maryland/Washington, DC, metropolitan area—Epidemiology and trends: 2002–2013. In Proceedings of the Community Epidemiology Work Group (pp. 1–27).
   Google Scholar
• Arum, C., Fraser, H., Artenie, A. A., Bivegete, S., Trickey, A., Alary, M., Astemborski, J., Iversen, J., Lim, A. G., MacGregor, L., Morris, M., Ong, J. J., Platt, L., Sack-Davis, R., van Santen, D. K., Solomon, S. S., Sypsa, V., Valencia, J., Van Den Boom, W., … Vickerman, P. (2021). Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: A systematic review and meta-analysis. The Lancet. Public Health, 6(5), e309–e323. https://doi.org/10.1016/S2468-2667(21)00013-X
   PubMed Web of Science ®Google Scholar
• Avery, L., Rotondi, N., McKnight, C., Firestone, M., Smylie, J., & Rotondi, M. (2019). Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: Results from a simulation study. BMC Medical Research Methodology, 19(1), 202. https://doi.org/10.1186/s12874-019-0842-5
   PubMed Web of Science ®Google Scholar
• Ball, L. J., Puka, K., Speechley, M., Wong, R., Hallam, B., Wiener, J. C., Koivu, S., & Silverman, M. S. (2019). Sharing of injection drug preparation equipment is associated with HIV infection: A cross-sectional study. Journal of Acquired Immune Deficiency Syndromes, 81(4), e99–e103. https://doi.org/10.1097/qai.0000000000002062
   PubMed Web of Science ®Google Scholar
• Barocas, J. A., Nall, S. K., Axelrath, S., Pladsen, C., Boyer, A., Kral, A. H., Meehan, A. A., Savinkina, A., Peery, D., Bien, M., Agnew-Brune, C., Goldshear, J., Chiang, J., Linas, B. P., Gonsalves, G., Bluthenthal, R. N., & Mosites, E. (2023). Population-level health effects of involuntary displacement of people experiencing unsheltered homelessness who inject drugs in US cities. JAMA, 329(17), 1478–1486. https://doi.org/10.1001/jama.2023.4800
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N. (1998). Syringe exchange as a social movement: A case study of harm reduction in Oakland, California. Substance Use & Misuse, 33(5), 1147–1171. https://doi.org/10.3109/10826089809062212
   PubMed Web of Science ®Google Scholar
• Bornstein, K. J., Coye, A. E., St Onge, J. E., Li, H., Muller, A., Bartholomew, T. S., & Tookes, H. E. (2020). Hospital admissions among people who inject opioids following syringe services program implementation. Harm Reduction Journal, 17(1), 30. https://doi.org/10.1186/s12954-020-00376-1
   PubMed Web of Science ®Google Scholar
• Broadwater, L. (2014). Baltimore wants to give out thousands more needles to drug users. Baltimore Sun, Jan 17.
   Google Scholar
• Broz, D., Wejnert, C., Pham, H. T., DiNenno, E., Heffelfinger, J. D., Cribbin, M., Krishna, N., Teshale, E. H., & Paz-Bailey, G. (2014). HIV infection and risk, prevention, and testing behaviors among injecting drug users—National HIV Behavioral Surveillance System, 20 US cities, 2009. Morbidity and Mortality Weekly Report. Surveillance Summaries, 63(6), 1–51.
   PubMed Web of Science ®Google Scholar
• CDC (2019, May 23). Syringe Services Programs (SSPs). Centers for Disease Control and Prevention. Retrieved September 21, 2020, from https://www.cdc.gov/ssp/index.html
   Google Scholar
• Centers for Disease Control and Prevention (2018). Managing HIV and hepatitis C outbreaks among people who inject drugs – A guide for state and local health departments. Retrieved April 22, from https://www.cdc.gov/hiv/pdf/programresources/guidance/cluster-outbreak/cdc-hiv-hcv-pwid-guide.pdf
   Google Scholar
• Centers for Disease Control and Prevention (2020). HIV infection risk, prevention, and testing behaviors among persons who inject drugs—National HIV behavioral surveillance: Injection drug use, 23 U.S. cities, 2018. HIV Surveillance Special Report 24. Retrieved March 14, from http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
   Google Scholar
• Centers for Disease Control and Prevention (2022). Issue brief: The role of housing in ending the HIV epidemic. Retrieved from https://www.cdc.gov/hiv/policies/data/role-of-housing-in-ending-the-hiv-epidemic.html
   Google Scholar
• Chiang, J. C., Bluthenthal, R. N., Wenger, L. D., Auerswald, C. L., Henwood, B. F., & Kral, A. H. (2022). Health risk associated with residential relocation among people who inject drugs in Los Angeles and San Francisco, CA: A cross sectional study. BMC Public Health, 22(1), 823. https://doi.org/10.1186/s12889-022-13227-4
   PubMed Web of Science ®Google Scholar
• Cooper, H. L. F., Linton, S., Kelley, M. E., Ross, Z., Wolfe, M. E., Chen, Y.-T., Zlotorzynska, M., Hunter-Jones, J., Friedman, S. R., Des Jarlais, D., Semaan, S., Tempalski, B., DiNenno, E., Broz, D., Wejnert, C., & Paz-Bailey, G. (2016). Racialized risk environments in a large sample of people who inject drugs in the United States. The International Journal on Drug Policy, 27, 43–55. https://doi.org/10.1016/j.drugpo.2015.07.015
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet. Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C. (2017). Harm reduction in the USA: The research perspective and an archive to David Purchase. Harm Reduction Journal, 14(1), 51. https://doi.org/10.1186/s12954-017-0178-6
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Feelemyer, J. P., Modi, S. N., Arasteh, K., & Hagan, H. (2012). Are females who inject drugs at higher risk for HIV infection than males who inject drugs: An international systematic review of high seroprevalence areas. Drug and Alcohol Dependence, 124(1–2), 95–107. https://doi.org/10.1016/j.drugalcdep.2011.12.020
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., & Holtzman, D. (2015). Syringe service programs for persons who inject drugs in urban, suburban, and rural areas – United States, 2013. MMWR. Morbidity and Mortality Weekly Report, 64(48), 1337–1341. https://doi.org/10.15585/mmwr.mm6448a3
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Sypsa, V., Feelemyer, J., Abagiu, A. O., Arendt, V., Broz, D., Chemtob, D., Seguin-Devaux, C., Duwve, J. M., Fitzgerald, M., Goldberg, D. J., Hatzakis, A., Jipa, R. E., Katchman, E., Keenan, E., Khan, I., Konrad, S., McAuley, A., Skinner, S., & Wiessing, L. (2020). HIV outbreaks among people who inject drugs in Europe, North America, and Israel. The Lancet. HIV, 7(6), e434–e442. https://doi.org/10.1016/S2352-3018(20)30082-5
   PubMed Web of Science ®Google Scholar
• El-Bassel, N., & Strathdee, S. A. J. J. O A I D S (2015). Women who use or inject drugs: An action agenda for women-specific, multilevel and combination HIV prevention and research. Journal of Acquired Immune Deficiency Syndromes, 69(Suppl 2), S182–S190. https://doi.org/10.1097/QAI.0000000000000628
   PubMed Web of Science ®Google Scholar
• Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., Costa, S., Costa, J., & Carneiro, A. V. (2017). Effectiveness of needle and syringe programmes in people who inject drugs – An overview of systematic reviews. BMC Public Health, 17(1), 309. https://doi.org/10.1186/s12889-017-4210-2
   PubMed Web of Science ®Google Scholar
• Gallagher, K. M., Sullivan, P. S., Lansky, A., & Onorato, I. M. (2007). Behavioral surveillance among people at risk for HIV infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Reports, 122(Suppl 1), 32–38. https://doi.org/10.1177/00333549071220S106
   PubMed Web of Science ®Google Scholar
• German, D., Glick, J., Sawyer, A., Gribbin, M., & Flynn, C. (2021). HIV infection risk, prevention, and testing behaviors among persons who inject drugs—Baltimore HIV behavioral surveillance: Injection drug use, 2018. Retrieved from https://health.maryland.gov/phpa/OIDEOR/CHSE/pages/behavioral-surveillance.aspx
   Google Scholar
• Gile, K. J. (2011). Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. Journal of the American Statistical Association, 106(493), 135–146. https://doi.org/10.1198/jasa.2011.ap09475
   Web of Science ®Google Scholar
• Gile, K. J., & Handcock, M. S. (2010). Respondent-driven sampling: An assessment of current methodology. Sociological Methodology, 40(1), 285–327. https://doi.org/10.1111/j.1467-9531.2010.01223.x
   PubMed Web of Science ®Google Scholar
• Gile, K. J., Johnston, L. G., & Salganik, M. J. (2015). Diagnostics for respondent-driven sampling. Journal of the Royal Statistical Society. Series A (Statistics in Society), 178(1), 241–269. https://doi.org/10.1111/rssa.12059
   PubMed Web of Science ®Google Scholar
• Hackman, J., Falade-Nwulia, O., Patel, E. U., Mehta, S. H., Kirk, G. D., Astemborski, J., Ray, S. C., Thomas, D. L., & Laeyendecker, O. (2020). Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Infection, Genetics and Evolution, 77, 104078. https://doi.org/10.1016/j.meegid.2019.104078
   PubMed Web of Science ®Google Scholar
• Handanagic, S., Finlayson, T., Burnett, J. C., Broz, D., Wejnert, C., Abrego, M., Al-Tayyib, A., Anderson, B., Barak, N., & Beckford, J. M. (2021). HIV infection and HIV-associated behaviors among persons who inject drugs—23 Metropolitan statistical areas, United States, 2018. MMWR. Morbidity and Mortality Weekly Report, 70(42), 1459–1465. https://doi.org/10.15585/mmwr.mm7042a1
   PubMed Web of Science ®Google Scholar
• Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174–199. https://doi.org/10.2307/3096941
   Web of Science ®Google Scholar
• Heckathorn, D. D. (2002). Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems, 49(1), 11–34. https://doi.org/10.1525/sp.2002.49.1.11
   Web of Science ®Google Scholar
• Henman, A. R., Paone, D., Des Jarlais, D. C., Kochems, L. M., & Friedman, S. R. (1998a). From ideology to logistics: The organizational aspects of syringe exchange in a period of institutional consolidation. Substance Use & Misuse, 33(5), 1213–1230. https://doi.org/10.3109/10826089809062215
   PubMed Web of Science ®Google Scholar
• Henman, A. R., Paone, D., Des Jarlais, D. C., Kochems, L. M., & Friedman, S. R. (1998b). Injection drug users as social actors: A stigmatized community’s participation in the syringe exchange programmes of New York City. AIDS Care, 10(4), 397–408. https://doi.org/10.1080/09540129850123939
   PubMed Web of Science ®Google Scholar
• Hotton, A., Mackesy-Amiti, M.-E., & Boodram, B. (2021). Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997–2017. Drug and Alcohol Dependence, 225, 108797. https://doi.org/10.1016/j.drugalcdep.2021.108797
   PubMed Web of Science ®Google Scholar
• Iversen, J., Wand, H., Gonnermann, A., & Maher, L. (2010). Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008. The International Journal on Drug Policy, 21(6), 471–476. https://doi.org/10.1016/j.drugpo.2010.04.004
   PubMed Web of Science ®Google Scholar
• Kabapy, A. F., Shatat, H. Z., & Abd El-Wahab, E. W. (2020). Attributes of HIV infection over decades (1982–2018): A systematic review and meta-analysis. Transboundary and Emerging Diseases, 67(6), 2372–2388. https://doi.org/10.1111/tbed.13621
   PubMed Web of Science ®Google Scholar
• Kenny, K. S., Kolla, G., Greig, S., Bannerman, M., Phillips, D., Altenberg, J., Strike, C., & Bayoumi, A. M. (2023). Association of illicit fentanyl use with injection risk practices among people who inject drugs. AIDS and Behavior, 27(6), 1757–1765. https://doi.org/10.1007/s10461-022-03908-x
   PubMed Web of Science ®Google Scholar
• Kim, N. J., Jin, H., McFarland, W., & Raymond, H. F. (2015). Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005–2012. The International Journal on Drug Policy, 26(12), 1238–1243. https://doi.org/10.1016/j.drugpo.2015.08.013
   PubMed Web of Science ®Google Scholar
• Lambdin, B. H., Bluthenthal, R. N., Zibbell, J. E., Wenger, L., Simpson, K., & Kral, A. H. (2019). Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. The International Journal on Drug Policy, 74, 299–304. https://doi.org/10.1016/j.drugpo.2019.10.004
   PubMed Web of Science ®Google Scholar
• Lancaster, K. E., Cooper, H. L., Browning, C. R., Malvestutto, C. D., Bridges, J. F., & Young, A. M. (2020). Syringe service program utilization, barriers, and preferences for design in rural Appalachia: Differences between men and women who inject drugs. Substance Use & Misuse, 55(14), 2268–2277. https://doi.org/10.1080/10826084.2020.1800741
   PubMed Web of Science ®Google Scholar
• Larney, S., Leung, J., Grebely, J., Hickman, M., Vickerman, P., Peacock, A., Stone, J., Trickey, A., Dumchev, K. V., Colledge, S., Cunningham, E. B., Lynskey, M., Mattick, R. P., & Degenhardt, L. (2020). Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence. The International Journal on Drug Policy, 77, 102656. https://doi.org/10.1016/j.drugpo.2019.102656
   PubMed Web of Science ®Google Scholar
• Linley, L., Johnson, A. S., Song, R., Wu, B., Hu, S., Gant, Z., Green, T. A., Gunnels, B., Hall, H. I., & Hernandez, A. (2020). Estimated HIV incidence and prevalence in the United States, 2014–2018.
   Google Scholar
• Linton, S. L., Cooper, H. L., Kelley, M. E., Karnes, C. C., Ross, Z., Wolfe, M. E., Des Jarlais, D., Semaan, S., Tempalski, B., DiNenno, E., Finlayson, T., Sionean, C., Wejnert, C., & Paz-Bailey, G. (2015). HIV infection among people who inject drugs in the United States: Geographically explained variance across racial and ethnic groups. American Journal of Public Health, 105(12), 2457–2465. https://doi.org/10.2105/ajph.2015.302861
   PubMed Web of Science ®Google Scholar
• Lopez, A. M., Thomann, M., Dhatt, Z., Ferrera, J., Al-Nassir, M., Ambrose, M., & Sullivan, S. (2022). Understanding racial inequities in the implementation of harm reduction initiatives. American Journal of Public Health, 112(S2), S173–S181. https://doi.org/10.2105/ajph.2022.306767
   PubMedGoogle Scholar
• Mascolini, M. (2017). Widening needle distribution cuts new HIV cases in Baltimore. International AIDS Society.
   Google Scholar
• Mateu-Gelabert, P., Guarino, H., Zibbell, J. E., Teubl, J., Fong, C., Goodbody, E., Edlin, B., Salvati, C., & Friedman, S. R. (2020). Prescription opioid injection among young people who inject drugs in New York City: A mixed-methods description and associations with hepatitis C virus infection and overdose. Harm Reduction Journal, 17(1), 22. https://doi.org/10.1186/s12954-020-00367-2
   PubMed Web of Science ®Google Scholar
• Maurer, L. A., Bass, S. B., Ye, D., Benitez, J., Mazzella, S., & Krafty, R. (2016). Trend analyses of users of a syringe exchange program in Philadelphia, Pennsylvania: 1999–2014. AIDS and Behavior, 20(12), 2922–2932. https://doi.org/10.1007/s10461-016-1393-y
   PubMed Web of Science ®Google Scholar
• Mehta, S. H., Astemborski, J., Kirk, G. D., Strathdee, S. A., Nelson, K. E., Vlahov, D., & Thomas, D. L. (2011). Changes in blood-borne infection risk among injection drug users. The Journal of Infectious Diseases, 203(5), 587–594. https://doi.org/10.1093/infdis/jiq112
   PubMed Web of Science ®Google Scholar
• Meyerson, B. E., Lawrence, C. A., Cope, S. D., Levin, S., Thomas, C., Eldridge, L. A., Coles, H. B., Vadiei, N., & Kennedy, A. (2019). I could take the judgment if you could just provide the service: Non-prescription syringe purchase experience at Arizona pharmacies, 2018. Harm Reduction Journal, 16(1), 57. https://doi.org/10.1186/s12954-019-0327-1
   PubMed Web of Science ®Google Scholar
• Nassau, T., Al-Tayyib, A., Robinson, W. T., Shinefeld, J., & Brady, K. A. (2020). The impact of syringe services program policy on risk behaviors among persons who inject drugs in 3 US cities, 2005–2015. Public Health Reports, 135(1_suppl), 138S–148S. https://doi.org/10.1177/0033354920930137
   PubMed Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet, 378(9791), 571–583. https://doi.org/10.1016/s0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Newman, K. B. T. (2016). Maryland GOP Governor Larry Hogan signs syringe access expansion legislation. Retrieved from https://drugpolicy.org/news/2016/05/maryland-gop-governor-larry-hogan-signs-syringe-access-expansion-legislation
   Google Scholar
• Nyamathi, A. M., & Salem, B. E. (2021). The impact of unstable housing on health. The Lancet. Public Health, 6(5), e265–e266. https://doi.org/10.1016/S2468-2667(21)00035-9
   PubMed Web of Science ®Google Scholar
• O’Keefe, D., Aung, S. M., Pasricha, N., Wun, T., Linn, S. K., Lin, N., Aitken, C., Hughes, C., & Dietze, P. (2018). Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar. The International Journal on Drug Policy, 58, 22–30. https://doi.org/10.1016/j.drugpo.2018.04.010
   PubMed Web of Science ®Google Scholar
• Paquette, C. E., & Pollini, R. A. (2018). Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug and Alcohol Dependence, 188, 239–250. https://doi.org/10.1016/j.drugalcdep.2018.03.049
   PubMed Web of Science ®Google Scholar
• Park, J. N., Footer, K. H., Decker, M. R., Tomko, C., Allen, S. T., Galai, N., & Sherman, S. G. (2019). Interpersonal and structural factors associated with receptive syringe-sharing among a prospective cohort of female sex workers who inject drugs. Addiction, 114(7), 1204–1213. https://doi.org/10.1111/add.14567
   PubMed Web of Science ®Google Scholar
• Park, J. N., Owczarzak, J., Urquhart, G., Morris, M., Weicker, N. P., Rouhani, S., & Sherman, S. G. (2022). HIV risk among urban and suburban people who inject drugs: Elevated risk among fentanyl and cocaine injectors in Maryland. AIDS and Behavior, 26(1), 277–283. https://doi.org/10.1007/s10461-021-03381-y
   PubMed Web of Science ®Google Scholar
• Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., Schechter, M. T., Rekart, M. L., & O’Shaughnessy, M. V. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS, 8(7), 437–445. https://doi.org/10.1258/0956462971920497
   PubMed Web of Science ®Google Scholar
• Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., Maher, L., Palmateer, N., Taylor, A., Bruneau, J., & Hickman, M. (2017). Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. The Cochrane Database of Systematic Reviews, 9(9), Cd012021. https://doi.org/10.1002/14651858.CD012021.pub2
   PubMed Web of Science ®Google Scholar
• Pouget, E. R., Hagan, H., & Des Jarlais, D. C. (2012). Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction, 107(6), 1057–1065. https://doi.org/10.1111/j.1360-0443.2011.03765.x
   PubMed Web of Science ®Google Scholar
• Reyes, J. C., Welch-Lazoritz, M., Zayas-Martinez, L., Khan, B., & Dombrowski, K. (2019). Prevalence and risk factors associated with homelessness among drug users in Puerto Rico. Puerto Rico Health Sciences Journal, 38(1), 54–59.
   PubMed Web of Science ®Google Scholar
• Riehman, K. S., Kral, A. H., Anderson, R., Flynn, N., & Bluthenthal, R. N. (2004). Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(2), 249–259. https://doi.org/10.1093/jurban/jth111
   PubMed Web of Science ®Google Scholar
• Rivera, A. V., DeCuir, J., Crawford, N. D., Amesty, S., & Lewis, C. F. (2014). Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010–2012. Drug and Alcohol Dependence, 144, 259–264. https://doi.org/10.1016/j.drugalcdep.2014.09.778
   PubMed Web of Science ®Google Scholar
• Ruan, Y., Chen, K., Hong, K., He, Y., Liu, S., Zhou, F., Qin, G., Chen, J., Xing, H., & Shao, Y. (2004). Community-based survey of HIV transmission modes among intravenous drug users in Sichuan, China. Sexually Transmitted Diseases, 31(10), 623–627. https://doi.org/10.1097/01.olq.0000140018.24262.4a
   PubMed Web of Science ®Google Scholar
• Ruiz, M. S., OʼRourke, A., Allen, S. T., Holtgrave, D. R., Metzger, D., Benitez, J., Brady, K. A., Chaulk, C. P., & Wen, L. S. (2019). Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia. Journal of Acquired Immune Deficiency Syndromes, 82(2), S148–S154. https://doi.org/10.1097/Qai.0000000000002176
   PubMedGoogle Scholar
• Sherman, S. G., & Purchase, D. (2001). Point defiance: A case study of the United States’ first public needle exchange in Tacoma, Washington. The International Journal on Drug Policy, 12(1), 45–57. https://doi.org/10.1016/s0955-3959(00)00074-8
   PubMedGoogle Scholar
• Spittal, P. M., Craib, K. J., Wood, E., Laliberté, N., Li, K., Tyndall, M. W., O’Shaughnessy, M. V., & Schechter, M. T. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal, 166(7), 894–899.
   PubMed Web of Science ®Google Scholar
• Stone, J., Artenie, A., Hickman, M., Martin, N. K., Degenhardt, L., Fraser, H., & Vickerman, P. (2022). The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: A modelling study. The Lancet. Public Health, 7(2), e136–e145. https://doi.org/10.1016/S2468-2667(21)00258-9
   PubMed Web of Science ®Google Scholar
• Streck, J. M., Klevens, R. M., O’Cleirigh, C., & Batchelder, A. W. (2023). Injection of methamphetamine has increased in Boston, Massachusetts: 5 Waves of Centers for Disease Control and Prevention state surveillance data. Journal of Addiction Medicine, 17(3), 349–352. https://doi.org/10.1097/adm.0000000000001107
   PubMed Web of Science ®Google Scholar
• Tempalski, B., Pouget, E. R., Cleland, C. M., Brady, J. E., Cooper, H. L., Hall, H. I., Lansky, A., West, B. S., & Friedman, S. R. (2013). Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992–2007. PLOS One, 8(6), e64789. https://doi.org/10.1371/journal.pone.0064789
   PubMed Web of Science ®Google Scholar
• Tobin, K. E., Kuramoto, S. J., Davey-Rothwell, M. A., & Latkin, C. A. J. A. (2011). The STEP into Action study: A peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction, 106(2), 366–375. https://doi.org/10.1111/j.1360-0443.2010.03146.x
   PubMed Web of Science ®Google Scholar
• Van Handel, M. M., Rose, C. E., Hallisey, E. J., Kolling, J. L., Zibbell, J. E., Lewis, B., Bohm, M. K., Jones, C. M., Flanagan, B. E., Siddiqi, A.-E.-A., Iqbal, K., Dent, A. L., Mermin, J. H., McCray, E., Ward, J. W., & Brooks, J. T. (2016). County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. Journal of Acquired Immune Deficiency Syndromes, 73(3), 323–331. https://doi.org/10.1097/QAI.0000000000001098
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Platt, J., Anakaraonye, A., Golub, S. A., Cunningham, C. O., Norton, B. L., Sevelius, J. M., & Blackstock, O. J. (2021). Considerations for the design of pre-exposure prophylaxis (PrEP) interventions for women: Lessons learned from the implementation of a novel PrEP intervention. AIDS and Behavior, 25(12), 3987–3999. https://doi.org/10.1007/s10461-021-03353-2
   PubMed Web of Science ®Google Scholar
• Wejnert, C., Hess, K. L., Hall, H. I., Van Handel, M., Hayes, D., Fulton, P., An, Q., Koenig, L. J., Prejean, J., & Valleroy, L. A. (2016). Vital signs: Trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs – United States. MMWR. Morbidity and Mortality Weekly Report, 65(47), 1336–1342. https://doi.org/10.15585/mmwr.mm6547e1
   PubMed Web of Science ®Google Scholar
• Whiteman, A., Burnett, J., Handanagic, S., Wejnert, C., Broz, D., & NHBS Study Group (2020). Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment-17 US cities, 2015. The International Journal on Drug Policy, 85, 102923. https://doi.org/10.1016/j.drugpo.2020.102923
   PubMed Web of Science ®Google Scholar
• Zhou, B., Cai, G. F. F., Lv, H. K. K., Xu, S. F. F., Wang, Z. T. T., Jiang, Z. G. G., Hu, C. G. G., & Chen, Y. D. D. (2019). Factors correlating to the development of hepatitis C virus infection among drug users-findings from a systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 16(13), 2345. https://doi.org/10.3390/ijerph16132345
   Web of Science ®Google Scholar
• Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181. https://doi.org/10.2105/ajph.2017.304132
   PubMed Web of Science ®Google Scholar